Foresee Genomics
Active
Cancer, Genomics, Healthcare

Business Overview

Genomic tests are the leading diagnostic tool for personalized therapy. However, the tests are expensive, require large investments in infrastructure and qualified personnel, laborious, and their interpretation is challenging. As a result the whole procedure is not accessible in routine clinical settings. To boost personalized treatments, there is a need for quick, user friendly and inexpensive test that is performed routinely at any clinic, similar to blood test.

Foresee Genomics is developing an innovative testing kit for identifying multiple cancer genomic markers simultaneously in a revolutionary process that combines molecular biology and computational analysis. Foresee Genomics offers dramatic reduction in diagnostic costs with comparison to present genomic tests, and replaces the need to hold costly genomic centers. The hands-on procedure is easy, fast, requires simple equipment, and designed for existing diagnostic labs in hospitals or clinical centers.

Foresee Genomics makes personalized therapy accessible to everyone, everywhere.

Founded
February 2017
Business model
B2B
Offering type
Hardware, Software
Investors
Sectors
Cancer, Genomics, Healthcare, Personalized Treatment

Founders

Foresee Genomics
Roi Feingersch
CEO

AI Technology Stack

AI application
Vertical AI

Similar Startups

Related Investors

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events

Sign up for Pro

  • Export lists (CSV, Excel) of startups and investors
  • View newly added AI startups
  • View investor emails
  • View investment funds and rounds sources
  • Advanced filters, sorting and search
  • Starting at just $15 per month